These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
667 related articles for article (PubMed ID: 2939790)
1. Concepts of clot lysis. Francis CW; Marder VJ Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790 [TBL] [Abstract][Full Text] [Related]
2. Thrombolytic therapy in the eighties. Verstraete M; Collen D Blood; 1986 Jun; 67(6):1529-41. PubMed ID: 2423156 [No Abstract] [Full Text] [Related]
3. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN; Kizim AI Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [TBL] [Abstract][Full Text] [Related]
4. [Tissue plasminogen activator: mechanism of action and thrombolytic properties]. Páramo JA; Collen D Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389 [No Abstract] [Full Text] [Related]
5. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Collen D; Lijnen HR Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451 [TBL] [Abstract][Full Text] [Related]
6. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. Marder VJ; Francis CW Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729 [No Abstract] [Full Text] [Related]
7. The fibrinolytic system in man. Collen D; Lijnen HR Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O; Rijken DC; Collen D Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339 [TBL] [Abstract][Full Text] [Related]
9. [Thrombolytics and their use]. Alessi MC; Juhan-Vague I Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996 [TBL] [Abstract][Full Text] [Related]
10. [Laboratory control of fibrinolytic therapy]. Vinazzer H Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):30-7. PubMed ID: 2427412 [TBL] [Abstract][Full Text] [Related]
11. The fibrinolytic system and its pharmacologic activation for thrombolysis. Sherry S Cardiol Clin; 1987 Feb; 5(1):1-11. PubMed ID: 2951008 [TBL] [Abstract][Full Text] [Related]
12. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Collen D Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468 [No Abstract] [Full Text] [Related]
13. [Pharmacological potentials for activating the fibrinolytic system]. Markwardt F Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126 [TBL] [Abstract][Full Text] [Related]
14. Effects of pro-urokinase and urokinase on the fibrinolytic system in man. Trübestein G; Popov S; Wolf H; Welzel D Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis--a review. Kane KK Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic system in atherosclerosis. Balkuv-Ulutin S Semin Thromb Hemost; 1986 Apr; 12(2):91-101. PubMed ID: 3738530 [TBL] [Abstract][Full Text] [Related]
17. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation. Hare TR; Gardell SJ Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic agents and their effects on the haemostatic system. Kluft C Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542 [TBL] [Abstract][Full Text] [Related]